Yunnan Baiyao Group Co.,Ltd (SHE:000538)

Market Cap	91.71B -9.4%
Revenue (ttm)	41.81B +2.4%
Net Income	5.22B +0.5%
EPS	2.92 +0.5%
Shares Out	1.78B
PE Ratio	17.59
Forward PE	16.01
Dividend	2.62 (5.10%)
Ex-Dividend Date	Sep 24, 2026

Volume	11,717,006
Open	50.25
Previous Close	50.89
Day's Range	50.25 - 51.62
52-Week Range	46.29 - 58.20
Beta	0.12
Analysts	Buy
Price Target	67.86 (+32.02%)
Earnings Date	Oct 30, 2026

About SHE:000538

Yunnan Baiyao Group Co.,Ltd engages in the sale of pharmaceuticals, medicinal materials, health and daily chemical products in China. The company offers health products; traditional Chinese medicine used for pain management and anti-inflammation, including the Yunnan Baiyao aerosol, Yunnan Baiyao ointment, and Yunnan Baiyao band-aid; generic drugs and natural specialty medicines in various areas, such as physical fitness, respiratory ailments, cardiovascular health, gynecology, pediatrics, and others; medical devices; tea products; and pharmace...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1902
• Employees: 9,286
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000538

Financial Performance

In 2025, SHE:000538's revenue was 41.19 billion, an increase of 2.88% compared to the previous year's 40.03 billion. Earnings were 5.15 billion, an increase of 8.51%.

Analyst Summary

According to 12 analysts, the average rating for 000538 stock is "Buy." The 12-month stock price target is ¥67.86, which is an increase of 32.02% from the latest price.

Price Target

¥67.86

(32.02% upside)

Analyst Consensus: Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 9, 2026

Data Sources Report a data error